Published in Int J Surg Case Rep on October 18, 2016
The SCARE Statement: Consensus-based surgical case report guidelines. Int J Surg (2016) 20.35
Conditional survival estimates improve over 5 years for melanoma survivors with node-positive disease. Ann Surg Oncol (2010) 1.24
Histologically ambiguous ("borderline") primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsy. Arch Pathol Lab Med (2010) 1.10
Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma. Am J Surg Pathol (2003) 1.10
AJCC melanoma staging update: impact on dermatopathology practice and patient management. J Cutan Pathol (2011) 1.02
Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma. Am J Surg Pathol (2002) 1.01
Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up. Mod Pathol (2010) 1.00
HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation. Am J Dermatopathol (1991) 0.98
Quantitative measurement of melanoma spread in sentinel lymph nodes and survival. PLoS Med (2014) 0.95
5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies. Mod Pathol (2014) 0.93
Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi. Am J Clin Pathol (2004) 0.92
Clinical characteristics and survival data of melanoma patients with nevus cell aggregates within sentinel lymph nodes. Am J Clin Pathol (2013) 0.83
False-positive rate of the immunoperoxidase stains for MART1/MelanA in lymph nodes. Am J Surg Pathol (2004) 0.83
Nuclear and cytoplasmic features in the diagnosis of banal nevi, Spitz nevi, and melanoma. J Am Acad Dermatol (2016) 0.80
Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma. Clin Exp Dermatol (2016) 0.79